Sfoglia per Autore
Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
1986 Peppoloni, Samuele; Herberman, R. B.; Gorelik, E.
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine
1986 Gorelik, E.; Peppoloni, Samuele; Overton, R.; Herberman, R. B.
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity
1987 Peppoloni, Samuele; Herberman, R. B.; Gorelik, E.
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets.
1987 Peppoloni, Samuele; Mathieson, B. J.; Herberman, R. B.; Overton, R. W.; Gorelik, E.
In vitro proliferation of human large granular lymphocytes with v-raf/v-myc recombinant retrovirus.
1988 Peppoloni, Samuele; Blasi, Elisabetta; Ortaldo, J. R.; Rapp, U. R.; Riccardi, C.; Varesio, L.
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity
1989 Peppoloni, Samuele; Bossu', P.; Boraschi, D.; Tagliabue, A.
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G
1990 Podda, A.; Nencioni, L.; DE MAGISTRIS, M. T.; DI TOMMASO, A.; Bossu', P.; Nuti, S.; Pileri, P.; Peppoloni, Samuele; Bugnoli, M.; Ruggiero, P.; Marsili, I.; Derrico, A.; Tagliabue, A. AND RAPPUOLI R.
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K
1991 Podda, A.; Nencioni, L.; Marsili, I.; Peppoloni, Samuele; Volpini, G.; Donati, D.; DI TOMMASO, A.; Magistris, M. T. AND RAPPUOLI R.
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment.
1991 Nencioni, L.; Volpini, G.; Peppoloni, Samuele; Bugnoli, M.; DE MAGISTRIS, M. T.; Marsili, I. AND RAPPUOLI R.
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification
1991 Verdini, A. S.; Pinori, M.; Viscomi, G. C.; Pileri, P.; Peppoloni, Samuele; Silvestri, S. AND NENCIONI L.
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis
1991 Peppoloni, Samuele; Nencioni, L.; DI TOMMASO, A.; Tagliabue, A.; Parronchi, P.; Romagnani, S.; Rappuoli, R. AND DE MAGISTRIS M. T.
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children.
1992 Podda, A.; CARAPELLA DE LUCA, E.; Titone, L.; Casadei, A. M.; Cascio, A.; Peppoloni, Samuele; Volpini, G.; Marsili, I.; Nencioni, L. AND RAPPUOLI R.
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children
1993 Podda, A.; CARAPELLA DE LUCA, E.; Titone, L.; Casadei, A. M.; Cascio, A.; Bartalini, M.; Volpini, G.; Peppoloni, Samuele; Marsili, I.; Nencioni, L. AND RAPPUOLI R.
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis
1994 Pizza, M. G.; Domenighini, M.; Hol, W.; Giannelli, V.; Fontana, M. R.; Giuliani, M. M.; Magagnoli, C.; Peppoloni, Samuele; Manetti, R.; Rappuoli, R.
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine.
1994 Podda, A.; CARAPELLA DE LUCA, E.; Contu, B.; Furlan, R.; Maida, A.; Moiraghi, A.; Stramare, D.; Titone, L.; Uxa, F.; DI PISA, F.; Peppoloni, Samuele; Nencioni, L.; RAPPUOLI R., AND THE ITALIAN MULTICENTER GROUP FOR THE STUDY OF RECOMBINANT ACELLULAR PERTUSSIS VACCINE
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin
1995 Peppoloni, Samuele; Pizza, M.; DE MAGISTRIS, M.; Bartoloni, A.; Rappuoli, R.
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.
1997 DI TOMMASO, A.; Bartalini, M.; Peppoloni, Samuele; Podda, A.; Rappuoli, R.; DE MAGISTRIS, M.
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery
2000 Mcneela, E.; O'Connor, D.; JABBAL GILL, I.; Illum, L.; Davis, S.; Pizza, M.; Peppoloni, Samuele; Rappuoli, R.; Mills, K.
Physicochemical characterisation of the pertussis vaccine.
2000 Ceccarini, C.; Contorni, M.; D'Ascenzi, S.; Gallo, E.; Maffei, M.; Mannucci, D.; Marsili, I.; Magagnoli, C.; Peppoloni, Samuele; Rappuoli, R.; Ravenscroft, N.; Ricci, S.
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii
2000 RICCI, S.; MEDAGLINI, B.; RUSH, C.; MARCELLO, A.; PEPPOLONI, Samuele; MANGANELLI, R.; PALU, G.; POZZI, G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation. | 1-gen-1986 | Peppoloni, Samuele; Herberman, R. B.; Gorelik, E. | |
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine | 1-gen-1986 | Gorelik, E.; Peppoloni, Samuele; Overton, R.; Herberman, R. B. | |
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity | 1-gen-1987 | Peppoloni, Samuele; Herberman, R. B.; Gorelik, E. | |
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. | 1-gen-1987 | Peppoloni, Samuele; Mathieson, B. J.; Herberman, R. B.; Overton, R. W.; Gorelik, E. | |
In vitro proliferation of human large granular lymphocytes with v-raf/v-myc recombinant retrovirus. | 1-gen-1988 | Peppoloni, Samuele; Blasi, Elisabetta; Ortaldo, J. R.; Rapp, U. R.; Riccardi, C.; Varesio, L. | |
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity | 1-gen-1989 | Peppoloni, Samuele; Bossu', P.; Boraschi, D.; Tagliabue, A. | |
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G | 1-gen-1990 | Podda, A.; Nencioni, L.; DE MAGISTRIS, M. T.; DI TOMMASO, A.; Bossu', P.; Nuti, S.; Pileri, P.; Peppoloni, Samuele; Bugnoli, M.; Ruggiero, P.; Marsili, I.; Derrico, A.; Tagliabue, A. AND RAPPUOLI R. | |
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K | 1-gen-1991 | Podda, A.; Nencioni, L.; Marsili, I.; Peppoloni, Samuele; Volpini, G.; Donati, D.; DI TOMMASO, A.; Magistris, M. T. AND RAPPUOLI R. | |
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment. | 1-gen-1991 | Nencioni, L.; Volpini, G.; Peppoloni, Samuele; Bugnoli, M.; DE MAGISTRIS, M. T.; Marsili, I. AND RAPPUOLI R. | |
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification | 1-gen-1991 | Verdini, A. S.; Pinori, M.; Viscomi, G. C.; Pileri, P.; Peppoloni, Samuele; Silvestri, S. AND NENCIONI L. | |
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis | 1-gen-1991 | Peppoloni, Samuele; Nencioni, L.; DI TOMMASO, A.; Tagliabue, A.; Parronchi, P.; Romagnani, S.; Rappuoli, R. AND DE MAGISTRIS M. T. | |
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. | 1-gen-1992 | Podda, A.; CARAPELLA DE LUCA, E.; Titone, L.; Casadei, A. M.; Cascio, A.; Peppoloni, Samuele; Volpini, G.; Marsili, I.; Nencioni, L. AND RAPPUOLI R. | |
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children | 1-gen-1993 | Podda, A.; CARAPELLA DE LUCA, E.; Titone, L.; Casadei, A. M.; Cascio, A.; Bartalini, M.; Volpini, G.; Peppoloni, Samuele; Marsili, I.; Nencioni, L. AND RAPPUOLI R. | |
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis | 1-gen-1994 | Pizza, M. G.; Domenighini, M.; Hol, W.; Giannelli, V.; Fontana, M. R.; Giuliani, M. M.; Magagnoli, C.; Peppoloni, Samuele; Manetti, R.; Rappuoli, R. | |
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. | 1-gen-1994 | Podda, A.; CARAPELLA DE LUCA, E.; Contu, B.; Furlan, R.; Maida, A.; Moiraghi, A.; Stramare, D.; Titone, L.; Uxa, F.; DI PISA, F.; Peppoloni, Samuele; Nencioni, L.; RAPPUOLI R., AND THE ITALIAN MULTICENTER GROUP FOR THE STUDY OF RECOMBINANT ACELLULAR PERTUSSIS VACCINE | |
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin | 1-gen-1995 | Peppoloni, Samuele; Pizza, M.; DE MAGISTRIS, M.; Bartoloni, A.; Rappuoli, R. | |
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. | 1-gen-1997 | DI TOMMASO, A.; Bartalini, M.; Peppoloni, Samuele; Podda, A.; Rappuoli, R.; DE MAGISTRIS, M. | |
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery | 1-gen-2000 | Mcneela, E.; O'Connor, D.; JABBAL GILL, I.; Illum, L.; Davis, S.; Pizza, M.; Peppoloni, Samuele; Rappuoli, R.; Mills, K. | |
Physicochemical characterisation of the pertussis vaccine. | 1-gen-2000 | Ceccarini, C.; Contorni, M.; D'Ascenzi, S.; Gallo, E.; Maffei, M.; Mannucci, D.; Marsili, I.; Magagnoli, C.; Peppoloni, Samuele; Rappuoli, R.; Ravenscroft, N.; Ricci, S. | |
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii | 1-gen-2000 | RICCI, S.; MEDAGLINI, B.; RUSH, C.; MARCELLO, A.; PEPPOLONI, Samuele; MANGANELLI, R.; PALU, G.; POZZI, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile